Sandrine Egron

Investment Director

2025

Investment Director - 50 Partners Health

2022

Portfolio companies: Pixacare, Surge, Jeen, Ensweet, Gutycare (Exit: acquired by Resilience), En Carta Diagnostics, Biohive, Glaaster, Medicud, Maisons Soma, Wyes. - Co-built 50 Partners Health, the first healthcare-focused accelerator within 50 Partners. - Launched the FPCI fund 50 Partners Capital Health. - Strategic support for portfolio startups.

Board Member

2024

Board Member

2022

Chief Operating Officer

2022 - 2022

Conducted on-ground fieldwork with the local team in Abidjan to refine healthcare assistance offerings and pricing strategy, while preparing partnerships with medical centers.

Co-founder and CEO

2018 - 2021

- Built a team of exceptional co-founders (Pr. Dinh Xuan Anh Tuan and Philippe Nguyen), medical professionals, and developers. - Developed a DTx platform for chronic respiratory disease patients, successfully tested with users. - Designed a clinical trial with Vietnam’s top 4 respiratory departments (suspended due to COVID-19). - Secured significant public exposure through media (press and national TV).

Leader Innovative Health Group

2019 - 2020

Appointed to guide the Innovative Health group of the ‘Club Santé Vietnam’: a lobbyist group which gathered 30 French healthcare companies active in Vietnam. (Among them: Sanofi, Servier, Urgo)

Life Sciences Consultant

2017 - 2018

Provided due diligence services for investment and consulting firms in the healthcare sector. (E.g. MD Start)

Co-Founder

2016 - 2017

Vivosim AI is based on proprietary algorithms which can be used to improve drug dosing strategies along cancer treatment cycles, for higher efficacy and safety in each patient. - Secured a pilot project in hemato-oncology with Innate Pharma (a listed biotech company specialized in immunotherapy) - Managed the pilot delivery, exceeding the expectations of Innate Pharma’s CMO and CTO

R&D Project Manager in Medical Device Development

2014 - 2016

At the Helmholtz Institute, Cardiovascular Engineering department (CVE): - Managed preclinical medical device development projects (heart valve prosthesis, embolic protection device). - Published seven articles and gave talks (in France, Germany, Poland) presenting independent research on the risks associated with cardiovascular interventions. -> Earned my PhD (Dr. rer. medic.) for this work